Breaking News Instant updates and real-time market news.

RBGLY

Reckitt Benckiser

$16.14

0.18 (1.13%)

, PFE

Pfizer

$36.27

-0.06 (-0.17%)

18:44
03/21/18
03/21
18:44
03/21/18
18:44

Reckitt Benckiser ends talks with Pfizer over Consumer Healthcare unit

Reckitt Benckiser (RBGLY) announced that it has ended discussions with Pfizer (PFE) regarding its Consumer Healthcare business. RB's proposal was for part of the business only. Rakesh Kapoor, RB CEO, said: "Our priority remains organic growth, including the completion of the integration of Mead Johnson Nutrition and creating further value from reorganising into two new business units - Health and Hygiene Home. We always approach inorganic growth opportunities in a rigorous, disciplined, and financially responsible manner to ensure long term value creation for shareholders. An acquisition for the whole Pfizer consumer health business did not fit our acquisition criteria and an acquisition of part of the business was not possible."

RBGLY

Reckitt Benckiser

$16.14

0.18 (1.13%)

PFE

Pfizer

$36.27

-0.06 (-0.17%)

  • 04

    Apr

RBGLY Reckitt Benckiser
$16.14

0.18 (1.13%)

07/06/17
JEFF
07/06/17
DOWNGRADE
JEFF
Hold
Reckitt Benckiser downgraded to Hold from Buy at Jefferies
Jefferies analyst Martin Deboo downgraded Reckitt Benckiser to Hold saying the recent share rally no longer leaves sufficient upside for a Buy rating. The analyst raised his price target to 8,400p from 7,750p.
PFE Pfizer
$36.27

-0.06 (-0.17%)

12/05/17
SBSH
12/05/17
NO CHANGE
Target $72
SBSH
Buy
Senate tax bill raises odds of Pfizer buying Bristol-Myers, says Citi
The Senate tax bill, which lowers the cost of bringing cash back home from outside the U.S., increases the probability of the "often-discussed" potential acquisition of Bristol-Myers Squibb (BMY) by Pfizer, Citi analyst Andrew Baum tells investors in a research note. The analyst points out that Pfizer has repeatedly underscored the importance of tax reform both from a competitive angle as well as from a merger perspective. Further, the analyst says that while Roche's (RHHBY) IMpower 150 Tecentriq lung cancer data in Geneva will take center stage this week, Bristol-Myers should benefit from two recent positive developments. The FDA's and Centers for Medicare and Medicaid Services' recommendation of Tumor Mutational Burden testing for lung cancer and other tumors will likely materially accelerate adoption and create more favorable reimbursement, Baum writes in a research note partially titled "Stars Converging for BMY." The analyst keeps a Buy rating on Bristol shares with a $72 price target. The stock closed yesterday down 76c to $62.47.
01/29/18
RHCO
01/29/18
NO CHANGE
Target $40
RHCO
Hold
Pfizer price target raised to $40 from $33 at SunTrust
SunTrust analyst John Boris raised his price target on Pfizer to $40 and kept his Hold rating ahead of this week's earnings. The analyst attributes the price outlook revision to the positive impact of the tax changes, but notes that "transformative large-scale M&A" is needed to bring about return to "robust" long-term growth.
02/07/18
HCWC
02/07/18
NO CHANGE
Target $31
HCWC
Buy
Achaogen price target raised to $31 from $25 at H.C. Wainwright
H.C. Wainwright analyst Ed Arce raised his price target for Achaogen (AKAO) to $31 after the FDA classified the outcome of its Q4 reinspection of Pfizer's (PFE) McPherson, Kansas facility as Voluntary Action Indicated. The news provides a clear regulatory path for approval of plazomicin out of the McPherson facility, Arce tells investors in a research note. He views the outcome as an "important risk-reducing development" that removes an overhang on Achaogen shares. The analyst keeps a Buy rating on the name.
02/16/18
SBSH
02/16/18
NO CHANGE
Target $78
SBSH
Buy
Three developments make Pfizer buying Bristol-Myers more likely, says Citi
Citi analyst Andrew Baum raised his price target for Bristol-Myers Squibb (BMY) to $78 from $72 saying three developments over the last week have increased the probability of a Pfizer (PFE) takeover to near 65% from 50%. Bristol closed yesterday up $3.64, or 5.6%, to $68.98. First, Bristol's revenue potential in non-small cell lung cancer is partly de-risked through Checkmate-227 tumor mutation burden data, Baum tells investors in a research note. Second, the NKTR-214 development collaboration and equity stake in Nektar Therapeutics (NKTR) could materially increase Bristol's Opdivo market share, the analyst adds. And third, he believes Pfizer's immuno-oncology efforts "are looking increasingly suspect." Bristol-Myers is likely Pfizer's last chance to have a meaningful position in the $50B-plus per annum immuno-oncology market, Baum contends. He reiterates a Buy rating on Bristol shares.

TODAY'S FREE FLY STORIES

CGC

Canopy Growth

$32.74

1.86 (6.02%)

11:25
08/17/18
08/17
11:25
08/17/18
11:25
Options
Canopy Growth call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$33.21

0.13 (0.39%)

, VIA

Viacom

$35.75

0.25 (0.70%)

11:19
08/17/18
08/17
11:19
08/17/18
11:19
Hot Stocks
Box Office Battle: 'Crazy Rich Asians' expected to edge out 'The Meg' »

The major release opening…

T

AT&T

$33.21

0.13 (0.39%)

VIA

Viacom

$35.75

0.25 (0.70%)

VIAB

Viacom

$30.60

0.5 (1.66%)

CMCSA

Comcast

$35.59

-0.07 (-0.20%)

CMCSK

Comcast

$0.00

(0.00%)

FOX

21st Century Fox

$44.86

-0.25 (-0.55%)

FOXA

21st Century Fox

$45.41

-0.3 (-0.66%)

LGF.A

Lionsgate

$22.90

-0.16 (-0.69%)

LGF.B

Lionsgate

$21.71

-0.24 (-1.09%)

SNE

Sony

$54.21

0.385 (0.72%)

DIS

Disney

$112.10

-0.39 (-0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

  • 11

    Sep

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
08/17/18
08/17
11:17
08/17/18
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
08/17/18
08/17
11:16
08/17/18
11:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:15
08/17/18
08/17
11:15
08/17/18
11:15
General news
Treasury Option Action: put butterfly positioning in the belly »

Treasury Option Action:…

BTC

Bitcoin

$0.00

(0.00%)

, BITCOIN

Bitcoin

$0.00

(0.00%)

11:13
08/17/18
08/17
11:13
08/17/18
11:13
Hot Stocks
The Intersection: Crypto and Wall Street This Week »

As bitcoin, ethereum and…

BTC

Bitcoin

$0.00

(0.00%)

BITCOIN

Bitcoin

$0.00

(0.00%)

TSM

TSMC

$39.87

-0.55 (-1.36%)

NVDA

Nvidia

$247.00

-10.57 (-4.10%)

AMD

AMD

$19.48

0.14 (0.72%)

OSTK

Overstock.com

$30.75

0.55 (1.82%)

DPW

DPW Holdings

$0.42

0.019 (4.76%)

KODK

Kodak

$2.90

-0.1 (-3.33%)

SSC

Seven Stars Cloud Group

$1.99

0.01 (0.51%)

RIOT

Riot Blockchain

$5.35

-0.055 (-1.02%)

TEUM

Pareteum

$2.52

-0.01 (-0.40%)

SRAX

Social Reality

$4.18

-0.16 (-3.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 28

    Aug

  • 12

    Sep

11:05
08/17/18
08/17
11:05
08/17/18
11:05
General news
The U.S. QSS figures »

The U.S. QSS figures that…

NVDA

Nvidia

$247.12

-10.45 (-4.06%)

, ESPR

Esperion

$48.10

1.41 (3.02%)

11:04
08/17/18
08/17
11:04
08/17/18
11:04
Recommendations
Fly Intel: Today's top analyst calls on Wall Street »

Check out today's…

NVDA

Nvidia

$247.12

-10.45 (-4.06%)

ESPR

Esperion

$48.10

1.41 (3.02%)

DSW

DSW

$25.85

-1.97 (-7.08%)

MTCH

Match Group

$46.87

0.49 (1.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 12

    Sep

  • 12

    Sep

FIBK

First Interstate

$45.20

(0.00%)

11:02
08/17/18
08/17
11:02
08/17/18
11:02
Hot Stocks
First Interstate completes acquisition of Northwest Bancorporation »

Effective August 16,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

LB

L Brands

$32.34

0.24 (0.75%)

11:00
08/17/18
08/17
11:00
08/17/18
11:00
Options
Defensive one-week option play in L Brands ahead of earnings »

Defensive one-week option…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

SYMC

Symantec

$19.44

0.115 (0.60%)

10:40
08/17/18
08/17
10:40
08/17/18
10:40
Options
Symantec sees in the money put buying »

Symantec sees in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

DE

Deere

$136.75

-0.63 (-0.46%)

10:39
08/17/18
08/17
10:39
08/17/18
10:39
Hot Stocks
Breaking Hot Stocks news story on Deere »

Deere says cash use…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

TSLA

Tesla

$313.73

-21.73 (-6.48%)

10:37
08/17/18
08/17
10:37
08/17/18
10:37
Technical Analysis
Technical Take: Tesla nearing bearish head and shoulders target »

In a note published here…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

PK

Park Hotels & Resorts

$32.15

-0.19 (-0.59%)

10:36
08/17/18
08/17
10:36
08/17/18
10:36
Hot Stocks
Park Hotels & Resorts mentioned positively by Hedgeye »

Hedgeye made positive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:35
08/17/18
08/17
10:35
08/17/18
10:35
General news
FX Action: Cable is set to rack up a sixth consecutive week of declines »

FX Action: Cable is set…

WBK

Westpac Banking

$21.99

0.09 (0.41%)

10:33
08/17/18
08/17
10:33
08/17/18
10:33
Downgrade
Westpac Banking rating change  »

Westpac Banking…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

DE

Deere

$137.29

-0.09 (-0.07%)

10:31
08/17/18
08/17
10:31
08/17/18
10:31
Hot Stocks
Deere expects FY18 net operating cash flows from equipment operations $3.5B »

Says had another…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

SPY

SPDR S&P 500 ETF Trust

$283.54

-0.55 (-0.19%)

10:30
08/17/18
08/17
10:30
08/17/18
10:30
Options
Bullish end of year play in SPYders »

Bullish end of year play…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:25
08/17/18
08/17
10:25
08/17/18
10:25
General news
The Michigan sentiment drop to an 11-month low »

The Michigan sentiment…

GERN

Geron

$3.99

0.04 (1.01%)

10:20
08/17/18
08/17
10:20
08/17/18
10:20
Options
Geron draws far upside call buyers »

Geron draws far upside…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

10:20
08/17/18
08/17
10:20
08/17/18
10:20
General news
U.S. leading indicator rose 0.6% to 110.7 in July »

U.S. leading indicator…

DARE

Dare Bioscience

$1.01

0.01 (1.00%)

, WSC

WillScot

$16.10

0.2 (1.26%)

10:18
08/17/18
08/17
10:18
08/17/18
10:18
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…click here.

DARE

Dare Bioscience

$1.01

0.01 (1.00%)

WSC

WillScot

$16.10

0.2 (1.26%)

LGND

Ligand

$237.18

-2.66 (-1.11%)

COT

Cott Corp.

$15.98

0.34 (2.17%)

AZRE

Azure Power

$15.95

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

DF

Dean Foods

$8.01

-0.62 (-7.18%)

, WAB

Wabtec

$108.87

-1.73 (-1.56%)

10:17
08/17/18
08/17
10:17
08/17/18
10:17
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…click here.

DF

Dean Foods

$8.01

-0.62 (-7.18%)

WAB

Wabtec

$108.87

-1.73 (-1.56%)

YUMC

Yum China

$34.48

-0.85 (-2.41%)

DSW

DSW

$25.77

-2.05 (-7.37%)

SUI

Sun Communities

$101.22

-0.895 (-0.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 10

    Sep

  • 12

    Sep

  • 06

    Nov

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
08/17/18
08/17
10:17
08/17/18
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
08/17/18
08/17
10:16
08/17/18
10:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.